In our fill-and-seal process, both peptides are co-dissolved against a single validated diluent volume before the pen is sealed
Safety Data Review Across published studies, CJC-1295 has demonstrated a favorable safety profile: Common Adverse Events Injection site reactions (redness, swelling, pain): the most frequently reported side effect Headache: mild and transient Diarrhea: reported in some subjects, particularly at higher doses Flushing: transient warmth or redness Dizziness: occasional and brief Serious Adverse Events One serious adverse event in the early clinical development program, a death that occurred in a subject during a study, drew attention
Overexpression of arylsulfate sulfotransferase as fusion protein with glutathione S-transferase
(PubMed) Cristofano A, Sapere N, La Marca G, et al
Oxidative stress markers, such as malondialdehyde (MDA), 8-hydroxy-2-deoxyguanosine (8-OHdG), and serum-free thiols (R-SH), can be measured in the blood and stool of patients with IBD